Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2ZOQ

Structural dissection of human mitogen-activated kinase ERK1

Summary for 2ZOQ
Entry DOI10.2210/pdb2zoq/pdb
DescriptorMitogen-activated protein kinase 3, SULFATE ION, SODIUM ION, ... (5 entities in total)
Functional Keywordsserine/threonine kinase, erk1, acetylation, atp-binding, cell cycle, host-virus interaction, nucleotide-binding, phosphoprotein, polymorphism, serine/threonine-protein kinase, transferase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight88077.91
Authors
Kinoshita, T.,Tada, T.,Nakae, S.,Yoshida, I. (deposition date: 2008-06-01, release date: 2009-04-07, Last modification date: 2024-10-30)
Primary citationKinoshita, T.,Yoshida, I.,Nakae, S.,Okita, K.,Gouda, M.,Matsubara, M.,Yokota, K.,Ishiguro, H.,Tada, T.
Crystal structure of human mono-phosphorylated ERK1 at Tyr204
Biochem.Biophys.Res.Commun., 377:1123-1127, 2008
Cited by
PubMed Abstract: Extracellular signal-regulated kinase (ERK) is a member of the MAP kinase family, and can regulate several cellular responses. The isoforms ERK1 and ERK2 have markedly similar amino acid sequences, but exhibit distinctive physiological functions. As well as ERK2, ERK1 was auto- and mono-phosphorylated at Tyr204 in the activation loop during Escherichia coli production, resulting in basal level activity, approximately 500-fold less compared with fully-active ERK1 dual-phosphorylated at Thr202 and Tyr204. Crystal structure demonstrated that the mono-phosphorylated ERK1 kinase possessed a novel conformation distinguishable from the un-phosphorylated (inactive) and the dual-phosphorylated (full-active) forms. The characteristic structural features in both the C-helix and the activation loop likely contribute to the basal activity of the mono-phosphorylated ERK1. The structural dissection of ERK1 compared to ERK2 suggests that the structural differences in the D-motif binding site and in the backside binding site are putative targets for development of selective ERK1/ERK2 inhibitors.
PubMed: 18983981
DOI: 10.1016/j.bbrc.2008.10.127
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.39 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon